Transplants benefit older people with haematologic cancers
Added: Monday 9 January 2012
US research suggests that elderly patients with advanced haematologic cancers do as well as younger patients when treated with allogenic hematopoietic cell transplants following non-myeloablative conditioning. (Non-myeloablative conditioning uses a less aggressive combination of chemotherapy and/or radiotherapy to prepare the patient for the transplant operation.) The researchers believe their findings should combat reluctance to enter elderly patients in non-myeloblative transplant protocols.
In order to be able to see the content from the www.medscape.com pages, please create first a free account at following link: